USANA HEALTH SCIENCES INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Usana Health Sciences Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Usana Health Sciences Inc Net Income (Loss) Attributable to Parent for the quarter ending September 28, 2024 was $10.6M, a 6.52% decline year-over-year.
  • Usana Health Sciences Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 28, 2024 was $54.3M, a 9.15% decline year-over-year.
  • Usana Health Sciences Inc annual Net Income (Loss) Attributable to Parent for 2023 was $63.8M, a 8.02% decline from 2022.
  • Usana Health Sciences Inc annual Net Income (Loss) Attributable to Parent for 2022 was $69.4M, a 40.5% decline from 2021.
  • Usana Health Sciences Inc annual Net Income (Loss) Attributable to Parent for 2021 was $117M, a 6.55% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $54.3M $10.6M -$740K -6.52% Jun 30, 2024 Sep 28, 2024 10-Q 2024-11-05
Q2 2024 $55.1M $10.4M -$6.86M -39.7% Mar 31, 2024 Jun 29, 2024 10-Q 2024-08-06
Q1 2024 $61.9M $16.5M -$1.85M -10% Dec 31, 2023 Mar 30, 2024 10-Q 2024-05-07
Q4 2023 $63.8M $16.8M +$3.97M +31% Oct 1, 2023 Dec 30, 2023 10-K 2024-02-27
Q3 2023 $59.8M $11.3M -$3.58M -24% Jul 2, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 $63.4M $17.3M -$1.87M -9.74% Apr 2, 2023 Jul 1, 2023 10-Q 2024-08-06
Q1 2023 $65.3M $18.4M -$4.09M -18.2% Jan 1, 2023 Apr 1, 2023 10-Q 2024-05-07
Q4 2022 $69.4M $12.8M -$7.53M -37% Oct 2, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $76.9M $14.9M -$12.4M -45.4% Jul 3, 2022 Oct 1, 2022 10-Q 2023-11-07
Q2 2022 $89.3M $19.2M -$19.1M -49.9% Apr 3, 2022 Jul 2, 2022 10-Q 2023-08-08
Q1 2022 $108M $22.5M -$8.15M -26.6% Jan 2, 2022 Apr 2, 2022 10-Q 2023-05-09
Q4 2021 $117M $20.3M -$19.3M -48.7% Oct 3, 2021 Jan 1, 2022 10-K 2024-02-27
Q3 2021 $136M $27.3M -$3.18M -10.4% Jul 4, 2021 Oct 2, 2021 10-Q 2022-11-08
Q2 2021 $139M $38.2M +$10.3M +36.7% Apr 4, 2021 Jul 3, 2021 10-Q 2022-08-09
Q1 2021 $129M $30.6M +$4.07M +15.3% Jan 3, 2021 Apr 3, 2021 10-Q 2022-05-11
Q4 2020 $125M $39.6M +$8.88M +28.9% Sep 27, 2020 Jan 2, 2021 10-K 2023-02-28
Q3 2020 $116M $30.5M +$6.28M +25.9% Jun 28, 2020 Sep 26, 2020 10-Q 2021-11-10
Q2 2020 $110M $28M +$6.6M +30.9% Mar 29, 2020 Jun 27, 2020 10-Q 2021-08-11
Q1 2020 $103M $26.6M +$2.38M +9.85% Dec 29, 2019 Mar 28, 2020 10-Q 2021-05-11
Q4 2019 $101M $30.8M -$1.58M -4.88% Sep 29, 2019 Dec 28, 2019 10-K 2020-02-25
Q3 2019 $102M $24.2M -$6.82M -22% Jun 30, 2019 Sep 28, 2019 10-Q 2020-11-03
Q2 2019 $109M $21.4M -$12.5M -37% Mar 31, 2019 Jun 29, 2019 10-Q 2020-08-04
Q1 2019 $121M $24.2M -$4.77M -16.5% Dec 30, 2018 Mar 30, 2019 10-Q 2020-05-05
Q4 2018 $126M $32.3M +$38.2M Sep 30, 2018 Dec 29, 2018 10-K 2020-02-25
Q3 2018 $88M $31M +$7.27M +30.6% Jul 1, 2018 Sep 29, 2018 10-K 2020-02-25
Q2 2018 $80.8M $33.9M +$10.6M +45.8% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-25
Q1 2018 $70.1M $28.9M +$7.59M +35.5% Dec 31, 2017 Mar 31, 2018 10-K 2020-02-25
Q4 2017 $62.5M -$5.85M -$27.7M -127% Oct 1, 2017 Dec 30, 2017 10-K 2019-02-26
Q3 2017 $90.3M $23.8M -$6.33M -21% Jul 2, 2017 Sep 30, 2017 10-K 2019-02-26
Q2 2017 $96.6M $23.3M -$2.5M -9.72% Apr 2, 2017 Jul 1, 2017 10-K 2019-02-26
Q1 2017 $99.1M $21.4M -$941K -4.22% Jan 1, 2017 Apr 1, 2017 10-K 2019-02-26
Q4 2016 $100M $21.9M -$2.09M -8.7% Oct 2, 2016 Dec 31, 2016 10-K 2018-02-28
Q3 2016 $102M $30.1M +$4.49M +17.5% Jul 3, 2016 Oct 1, 2016 10-K 2018-02-28
Q2 2016 $97.6M $25.8M +$346K +1.36% Apr 3, 2016 Jul 2, 2016 10-K 2018-02-28
Q1 2016 $97.3M $22.3M +$2.62M +13.3% Jan 3, 2016 Apr 2, 2016 10-K 2018-02-28
Q4 2015 $94.7M $24M +$2.67M +12.5% Oct 4, 2015 Jan 2, 2016 10-K 2017-03-01
Q3 2015 $92M $25.6M +$6.11M +31.3% Jul 5, 2015 Oct 3, 2015 10-K 2017-03-01
Q2 2015 $85.9M $25.4M +$6.12M +31.7% Apr 5, 2015 Jul 4, 2015 10-K 2017-03-01
Q1 2015 $79.8M $19.7M +$3.14M +19% Jan 4, 2015 Apr 4, 2015 10-K 2017-03-01
Q4 2014 $76.6M $21.3M +$1.02M +5.02% Sep 28, 2014 Jan 3, 2015 10-K 2016-03-01
Q3 2014 $75.6M $19.5M +$2.75M +16.4% Jun 29, 2014 Sep 27, 2014 10-K 2016-03-01
Q2 2014 $72.9M $19.3M -$4.91M -20.3% Mar 30, 2014 Jun 28, 2014 10-K 2016-03-01
Q1 2014 $77.8M $16.5M -$1.24M -6.99% Dec 29, 2013 Mar 29, 2014 10-K 2016-03-01
Q4 2013 $79M $20.3M +$1.84M +9.95% Sep 29, 2013 Dec 28, 2013 10-K 2015-03-17
Q3 2013 $77.2M $16.8M -$737K -4.21% Jun 30, 2013 Sep 28, 2013 10-K 2015-03-17
Q2 2013 $77.9M $24.2M +$7.47M +44.6% Mar 31, 2013 Jun 29, 2013 10-K 2015-03-17
Q1 2013 $70.5M $17.8M +$4.03M +29.3% Dec 30, 2012 Mar 30, 2013 10-K 2015-03-17
Q4 2012 $66.4M $18.4M +$5.29M +40.2% Sep 30, 2012 Dec 29, 2012 10-K 2014-03-13
Q3 2012 $61.1M $17.5M +$5.11M +41.2% Jul 1, 2012 Sep 29, 2012 10-K 2014-03-13
Q2 2012 $56M $16.7M +$2.89M +20.9% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-13
Q1 2012 $53.2M $13.8M +$2.4M +21.2% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-13
Q4 2011 $50.8M $13.2M Oct 2, 2011 Dec 31, 2011 10-K 2013-03-11
Q3 2011 $12.4M -$464K -3.61% Jul 3, 2011 Oct 1, 2011 10-K 2013-03-11
Q2 2011 $13.9M +$3.09M +28.7% Apr 3, 2011 Jul 2, 2011 10-K 2013-03-11
Q1 2011 $11.4M Jan 2, 2011 Apr 2, 2011 10-K 2013-03-11
Q3 2010 $12.8M Jul 4, 2010 Oct 2, 2010 10-Q 2011-11-09
Q2 2010 $10.8M Apr 4, 2010 Jul 3, 2010 10-Q 2011-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.